Metropolis Healthcare Limited
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East.
What Metropolis files
- Others61
- Investor Meet54
- Important33
- Updates23
- PPTs10
- Board Meeting9
Metropolis Healthcare has allotted 66,312 equity shares at INR 2 each under its employee stock unit plan, raising the total issued share capital to INR 41.49 crore. Half of these newly issued shares carry a one-year lock-in period.
Metropolis Healthcare’s subsidiary, MQSPL, has entered into subscription and shareholder agreements to restructure and scale its external quality assessment services business. Following incoming investments and phased conversions, MHL will hold a 54.90% stake, consolidating its operational leadership and R&D capabilities.
Metropolis Healthcare reported FY26 revenue of INR 1,646 Cr, with Q1 showing 17% growth. Management aims for 27-28% EBITDA margins (from 24.4%) driven by increased volumes and asset utilization. Strategic levers include expanding its 5,000+ center network, growing its TruHealth wellness packages (now 20% of business), and increasing high-margin specialty...
An audio recording of the Investors & Analyst Meet is now available on the company's website.
Metropolis Healthcare transferred its EQAS Division to its subsidiary, MQSPL, for INR 1.25 Cr. The consideration was paid through MQSPL equity shares. MQSPL will now manage all EQAS operations.